Serial-Number Recalls and UDI Traceability: What the GORE VIABAHN Notice Teaches Canadian Device Importers

In September 2026, W. L. Gore and Associates began a recall of its GORE VIABAHN Endoprosthesis with PROPATEN Bioactive, a vascular device. The Canadian recall record, posted on the Health Canada recalls database as RA-82600, explains that quality control testing found some devices were processed with equipment functioning outside of its validated range. That deviation could result in an incorrect bonding location of the distal tip onto the delivery catheter. Health Canada classified it as a Type II recall.

The detail that matters for importers and distributors is how the affected product is identified. The recall is scoped to specific catalogue numbers and to specific lot or serial numbers, not to the entire product line. To act on a recall like this, you must be able to match individual serial and lot numbers to the customers who received them, quickly and accurately. In Canada there is no national unique device identification database to do that for you. Your own distribution records are the system. This article explains what the Medical Devices Regulations require, where unique device identification (UDI) fits, and how to be ready before a recall tests you.

Executive summary

A serial-number or lot-level recall only works if you can trace specific units to specific customers. Canada's Medical Devices Regulations require importers and distributors to keep distribution records that allow a complete and quick market withdrawal, to report a recall on a fixed timeline, and to hold documented recall procedures. Canada has no mandatory UDI database, so those records carry the load.

• What happened: a GORE VIABAHN recall (RA-82600, Type II) scoped to specific catalogue, lot and serial numbers after an equipment validation deviation.
• Why it matters: you can only recall what you can trace; serial and lot level scope tests your distribution records directly.
• The Canadian rule: distribution records under sections 52 to 56, recall reporting under sections 63 to 65.1, and a 24 hour notification clock.
• Where UDI fits: mandatory in the United States and the European Union, but only explored in Canada so far, so Canadian traceability rests on your records.

What happened: the GORE VIABAHN recall

The recall is a performance issue, not a contamination or sterility failure. Gore found that some devices were made with equipment running outside its validated range, which could affect where the distal tip bonds to the delivery catheter. That is a classic reminder that equipment qualification and process validation are patient-safety controls, not paperwork. The Canadian record identifies the affected product by three catalogue numbers and by a defined set of lot or serial numbers, and directs customers to contact the manufacturer for the full list.

The same device family was also subject to field safety action in Europe, which is common for globally distributed devices. For a Canadian importer or distributor, the European notice does not change your duties, but it does raise the odds that a customer or clinician asks you about it first. You can review the Health Canada recall record for the GORE VIABAHN endoprosthesis for the official Canadian details.

What a serial-number recall demands of you

A recall scoped to serial or lot numbers is harder than a full product recall, because you cannot simply pull everything. You must identify the exact units in scope, find where each one went, and reach the people who hold them. If your records only track totals by product code, or if serial numbers were never captured at receipt and shipment, you cannot answer the one question Health Canada and your customers will ask: which of my units are affected, and where are they now.

For importers and distributors this is an operational test. The manufacturer defines the scope, but you execute the withdrawal in the Canadian market. That means matching the recalled catalogue, lot and serial numbers against your inbound receiving records and your outbound sales, then notifying each consignee and tracking their response. The quality of that match is set long before the recall, by the way you capture identifiers every day.

Canada's recall rules: what you must report and when

Under the Medical Devices Regulations, a manufacturer or importer that recalls a device likely to cause injury, or that could cause serious injury, must report to Health Canada on a set schedule. The duties fall on manufacturers and importers; retailers and health care facilities that only distribute within their own walls are generally exempt. The three reporting points are a 24 hour notification, an initial report, and a final report.

Health Canada's Guide for recalling medical devices (GUI-0054) sets out the detail. The table below summarizes the reporting points and timelines. You can read the full GUI-0054 recall reporting and process guidance for the complete content requirements.

One practical provision is worth knowing. Under section 65.1, a manufacturer may allow its sole Canadian importer to prepare and submit the recall information on its behalf, if the content is identical and both parties confirm the arrangement to Health Canada in writing. Importers should settle who files what before a recall, not during one. Separately, serious-risk incidents for Class II, III and IV devices carry their own mandatory problem reporting duty, generally within 72 hours.

Distribution records: the backbone of a recall

Sections 52 to 56 of the Medical Devices Regulations require manufacturers, importers and distributors to keep a distribution record for each device and a documented procedure for maintaining it. The record must hold enough information to let you withdraw the device from the market completely and quickly. Under section 55, you keep the record for the longer of the projected useful life of the device or two years after it is shipped. Health Canada's guidance on medical device establishment licensing (GUI-0016) sets out these record, complaint and recall duties for MDEL holders.

The phrase completely and quickly is the test. A distribution record that captures only product codes and quantities will not pass a serial-number recall. To withdraw specific units, the record needs to tie each lot or serial number you received to each one you shipped and to the customer who received it. This is also where distributors have a defined role: under paragraph 45(g) they must have procedures to carry out a recall, and they must act when one is called.

Where UDI fits, and where Canada actually stands

Unique device identification is a system of standardized codes that identify a device down to the production level, such as its lot or serial number. In the United States, UDI is mandatory and the data lives in the FDA Global Unique Device Identification Database (GUDID). In the European Union, UDI is required under the Medical Device Regulation and the In Vitro Diagnostic Regulation, with data registered in EUDAMED. These systems are designed to make exactly this kind of serial-level recall faster to execute.

Canada is not there yet. Health Canada ran a feasibility consultation on a Canadian UDI system that closed in 2021, and has signalled that further consultation would follow if it chose to proceed. There is no mandatory UDI requirement in the Medical Devices Regulations today. The practical consequence is important: in Canada, traceability is not delivered by a national database, it is delivered by your distribution records. Firms that already carry UDI for the United States or the European Union should use those identifiers in their Canadian records, and our guide to EUDAMED and the EU UDI system shows how the pieces connect for firms selling in more than one market.

What to do now: recall-readiness for importers and distributors

Recall-readiness is built in calm times and spent in a crisis. The steps below close the gaps a serial-number recall exposes.

• Step 1. Capture identifiers at both ends. Record lot, batch and serial numbers at receiving and at shipment, so every unit can be traced in and out.
• Step 2. Confirm your distribution record meets section 55. It must allow a complete and quick withdrawal and be retained for the longer of the device's useful life or two years after shipment.
• Step 3. Keep a current recall procedure. Name roles, set the 24 hour notification path, and hold templates for the initial and final reports and for customer notices in English and French.
• Step 4. Settle the s.65.1 arrangement. If you are a sole importer, agree in writing with the manufacturer who files the recall reports before a recall occurs.
• Step 5. Run a mock recall. Test whether you can resolve a specific lot or serial number to its customers within hours, and measure your effectiveness check.
• Step 6. Reuse UDI data you already hold. If devices carry a US or EU UDI, record it in your Canadian system so your traceability is consistent across markets.

Recall-readiness compliance checklist

• Lot, batch and serial numbers are captured at both receiving and shipment.
• The distribution record permits a complete and quick market withdrawal and meets the section 55 retention period.
• A documented recall procedure exists, with named roles and a 24 hour notification path.
• Templates are ready for the s.64 initial report, the s.65 final report, and bilingual customer notices.
• The sole-importer reporting arrangement under section 65.1 is agreed in writing where it applies.
• Complaint and problem-report records link to the same device identifiers, with the 72 hour serious-risk clock understood.
• A mock recall has been run in the last 12 months, with an effectiveness check recorded.
• US or EU UDI data, where it exists, is recorded in the Canadian distribution system.

Common mistakes to avoid

• Tracking only product codes and quantities. A serial-number recall needs unit-level records, not totals.
• Assuming Canada has a UDI database to fall back on. It does not. Your distribution records are the only traceability system that counts here.
• Discovering the 24 hour clock during a recall. The notification timeline starts when you decide to recall, so the procedure must already exist.
• Leaving the sole-importer reporting question open. Without a written section 65.1 arrangement, reports can be missed or duplicated.
• Skipping the effectiveness check. A recall is not complete when notices go out; it is complete when you can show units were recovered, corrected or accounted for.

Frequently asked questions

Does Canada require unique device identification (UDI)?

No. There is no mandatory UDI system in the Medical Devices Regulations. Health Canada explored the idea in a feasibility consultation that closed in 2021 and said further consultation would follow if it decided to proceed. Canadian traceability currently rests on the distribution records required under sections 52 to 56.

How quickly must a device recall be reported in Canada?

For a reportable recall, a manufacturer or importer must notify Health Canada within 24 hours of deciding to recall, submit an initial report on or before undertaking the recall, and submit a final report within 30 days of completing it.

How long must distribution records be kept?

Under section 55 of the Medical Devices Regulations, you keep the distribution record for the longer of the projected useful life of the device or two years after the device is shipped. The record must let you withdraw the device completely and quickly.

Who reports a recall when there is a foreign manufacturer and a Canadian importer?

Both the manufacturer and the importer have duties. Under section 65.1, a manufacturer may allow its sole Canadian importer to prepare and submit identical recall information on its behalf, provided both parties confirm the arrangement to Health Canada in writing. Agree this before a recall arises.

What triggered the GORE VIABAHN recall?

Gore identified through quality control testing that some devices were processed with equipment functioning outside its validated range, which could cause an incorrect bonding location of the distal tip onto the delivery catheter. Health Canada listed it as a Type II recall under record RA-82600.

What is a mock recall and why run one?

A mock recall is a rehearsal that tests whether you can trace a specific lot or serial number to its customers and recover or account for units within a target time. It exposes record gaps before a real recall does, and the result is strong evidence of recall-readiness during an inspection.

How MFLRC can help

MFLRC helps importers and distributors build recall-readiness that holds up under pressure. Through our medical device regulatory support, we assess your distribution records and traceability, write or upgrade recall and complaint procedures, and prepare your bilingual report templates. Our deep-dive on medical device recall reporting and the 24-hour clock pairs with hands-on mock audits and inspection-readiness and mock recalls, so you find the gaps on your schedule, not Health Canada's. We also support MDEL applications, QMS build, gap assessments and CAPA.

If you import or distribute devices in Canada and have not tested your traceability against a serial-number recall, now is the time.

Conclusion

The GORE VIABAHN recall is a routine Type II notice, and that is exactly why it is instructive. Most recalls are not dramatic. They are scoped to a handful of lot or serial numbers and they test one thing: can you find the affected units and the people who hold them. In Canada, where no UDI database stands behind you, the answer lives entirely in your distribution records and your recall procedure. Build that capability before a notice forces the question, and a recall becomes a controlled process rather than a scramble.

Sources and references

• Health Canada, Recalls and Safety Alerts: GORE VIABAHN Endoprosthesis with PROPATEN Bioactive (RA-82600)
• Health Canada, Guide for recalling medical devices (GUI-0054): recall reporting and process
• Medical Devices Regulations (SOR/98-282), Justice Laws Website
• Health Canada, Guidance on medical device establishment licensing (GUI-0016): other regulatory requirements
• Health Canada, Consultation on a Unique Device Identification (UDI) system for medical devices in Canada